Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Correction in Children With Autism Spectrum Disorder
NCT05595044Phase 1Unknown
- Sponsor
- Mansoura University
- Start
- Oct 2020
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vitamin d in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Mansoura University. Primary endpoints: Language ability test at 4 months, Childhood Autism Rating Scale at 4 months and 2 more. Status: unknown.
02
Drugs
vitamin d
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT05595044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05595044.